Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Fukushima

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting ReportLucy B Cook, Shigeo Fuji, Olivier Hermine, et al.
International Journal of Hematology|February 27, 2007
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, JapanEmi Matsuo, Yasushi Miyazaki, Chizuko Tsutsumi, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
International Journal of Hematology|March 7, 2009
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study GroupMari Sakai, Yasushi Miyazaki, Emi Matsuo, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting ReportLucy B Cook, Shigeo Fuji, Olivier Hermine, et al.
International Journal of Hematology|February 27, 2007
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, JapanEmi Matsuo, Yasushi Miyazaki, Chizuko Tsutsumi, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
International Journal of Hematology|March 7, 2009
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study GroupMari Sakai, Yasushi Miyazaki, Emi Matsuo, et al.
Pageof 14